Serum bioactive and immunoreactive luteinizing hormone in man: A multicentric study;Mesure de l'activite biologique de la hLH. Etude multicentrique

Annales de Biologie Clinique

Volumn 55, Issue 2, 1997, Pages 123-128

  Revol, A ^a   Carreau, S ^b   Castanier, M ^c   Collet, C ^d   Denis, I ^b   Guilloteau, D ^d   Moatti, J P ^e   Patricot, M C ^a   Roger, M ^c  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

^c Fondation de Rech en Hormonologie   (France)

^d CHU BRETONNEAU   (France)

^e Serv Univ Psychiat l'Enfant l'A   (France)

Author keywords

bioactivity; hLH; luteotropin; multicentric study

Indexed keywords

LUTEINIZING HORMONE; PROLACTIN; TESTOSTERONE;

ADULT; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; FEMALE; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; LEYDIG CELL; MALE; MOUSE; MULTICENTER STUDY; NONHUMAN; QUALITY CONTROL; RAT; SWINE; ANIMAL; BIOASSAY; BLOOD; CHEMISTRY; CLINICAL TRIAL; METHODOLOGY; MIDDLE AGED; STANDARD;

ANIMALIA; SUS SCROFA;

ADULT; ANIMALS; BIOLOGICAL ASSAY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LEYDIG CELLS; LUTEINIZING HORMONE; MALE; MICE; MIDDLE AGED; RATS; SWINE; TESTOSTERONE;

EID: 0031091434     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Leendert A, Van Ginkel LA, Somers HHJ, Loeber JG. Heterogeneity of human luteinizing hormone. Hydrophobic interaction, chromatographic fractionation of some preparations. Acta Endocrinol 1991 ; 125 : 73-9.
2. Costagliola S, Niccoli P, Carayon P, Glycoprotein hormone isomorphism and assay discrepancy : The paradigm of luteinizing hormone (LH). J Endocrinol Invest 1994 ; 17 : 291-9.
3. Pettersson KSI, Söderholm JRM. Individual differences in lutotropin immunoreactivity revealed by monoclonal antibodies. Clin Chem 1991 ; 37 : 333-40.
4. Jaakkola T, Ding YQ, Kellokumpu-Lehtinen P, Valavaara R, Martikainen H, Tapanainen J, Rönnberg L, Huhtaniemi I. The ratios of serum bioactive/immunoactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion : reevaluation by a highly sensitive immunometric assay. J Clin Endocrinol Metab 1990 ; 70 : 1496-505.
5. Huhtaniemi I, Haavisto AM, Anttila R, Siimes MA, Dunkel L. Sensitive immunoassay and in vitro bioassay demonstrate constant bioactive/immunoreactive ratio of luteinizing hormone in healthy boys during the pubertal maturation. Pediatr Res 1996 ; 39 : 180-4.
6. Revol A, Badonnel Y, Carreau S, Castanier M, Collet C, Delvigne L, et al. Immunodosage et mesure de l'activité biologique de la hLH sérique : résultats obtenus lors d'une étude multicentrique. Ann Biol Clin 1994 ; 52 : 671-80.
7. Roger M, Lalhou N. Heterogeneity of plasma gonadotropins. Consequences on immunological properties of LH. Nucl Med Biol 1994 ; 21 : 349-57.
8. Dufau ML, Mendelson CR, Catt KJ. A highly sensitive in vitro bioassay for luteinizing hormones and chorionic gonadotropin : testosterone production by dispersed Leydig cells. J Clin Endocrinol Metab 1974 ; 39 : 610-3.
9. Van Damme MP, Robertson DM, Diczfaluzy E. An improved in vitro bioassay method for measuring luteinizing hormone (LH) activity using mouse Leydig cell preparations. Acta Endocrinol 1974 ; 42 : 958-69.
10. Benahmed M, Reventos J, Saez JM. Steroidogenesis of cultured purified Leydig cells : effect of lipoproteins and human chorionic gonadotropin. Endocrinology 1983 ; 112 : 1952-7.
11. Castanier M, Beyer ML, Gervasi G, Scholler R. Effet de la matrice plasmatique sur le dosage biologique de la hLH plasmatique utilisant des cellules isolées de Leydig de rat. Pathol Biol 1991 ; 39 : 1010.
12. Janszen FHA, Cooke BA, Van Driel MJA, Van Der Molen HJ. Purification and characterization of Leydig cells from rat testes. J Endocrinol 1976 ; 70 : 345-59.
13. 5-3β-hydroxysteroid dehydrogenase (3β-HSD) in testicular cell. Endocrinology 1966 ; 79 : 406-10.
14. Ding YQ, Ranta T, Nikkanen V, Huhtaniemi I. Discordant levels of serum bioactive LH in man as measured in different in vitro bioassay systems using rat and mouse interstitial cells and human granulosaluteal cells. J Endocrinol 1991 ; 128 : 131-7.
15. Huhtaniemi I, Bolton N, Leinonen P, Kontturi M, Vihko R. Testicular luteinizing hormone receptor content and in vitro stimulation of cyclic adenosine 3′,5′-monophosphate and steroid production : a comparison between man and rat. J Clin Endocrinol Metab 1982 ; 55 : 882-9.
16. Mather JP, Saez JM, Haour F. Primary cultures of Leydig cells from rat, mouse and pig : advantages of porcine cells for the study of gonadotropin regulation of Leydig cell function. Steroids 1981 ; 38 : 35-44.
17. Burstein S, Schaff-Blass E, Blass J, Rosenfield L. The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics. J Clin Endocrinol Metab 1985 ; 61 : 508-13.
18. Carani C, Celani MF, Zini D, Baldini A, Della Casa L, Marrama P. Changes in the bioactivity to immunoreactivity ratio of circulating luteinizing hormone in impotent men treated with testosterone undecanoate. Acta Endocrinologica 1989 ; 120 : 284-8.
19. Fabbri A, Jannini EA, Ulisse S, Gnessi L, Moretti C, Frajese G, Isidori A. Low serum bioactive luteinizing hormone in nonorganic male impotence : possible relationship with altered gonadotropin-releasing hormone pulsatility. J Clin Endocrinol Metab 1988 ; 67 : 867-75.
20. Fauser BCJM, Pache TD, Lamberts SWJ, Hop WCJ, de Jong H, Dahl KD. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease. J Clin Endocrinol Metab 1991 ; 73 : 811-7.
21. Marrama P, Zaidi AA, Montanini V, Celani MF, Cioni K, Carani C, et al. Age and sex related variations in biologically active and immunoreactive serum luteinizing hormone. J Endocrinol Invest 1983 ; 6 : 427-33.
22. Montanini V, Celani FM, Baraghini GF, Carani C, Marrama P. Effects of acute stimulation with luteinizing hormone-releasing hormone (LRH) on biologically active and immunoreactive serum luteinizing hormone (LH) in pubertal boys. Acta Endocrinol 1984 ; 107 : 289-94.
23. Reiter EO, Beitins IZ, Ostrea T, Gutai JP. Bioassayable luteinizing hormone during childhood and adolescence and in patients with delayed pubertal development. J Clin Endocrinol Metab 1982 ; 54 : 155-61.
24. Veldhuis JD, Johson ML, Dufau ML. Preferential release of bioactive luteinizing hormone in response to endogenous and low dose exogenous gonadotropin-releasing hormone pulses in man. J Clin Endocrinol Metab 1987 ; 64 : 1275-82.
25. Denis I, Drosdowsky MA, Carreau S. Albumins and Leydig cell testosterone production in the immature rat. Horm Metab Res 1994 ; 26 : 55-6.
26. Chappel S. Editorial : biological to immunological ratios : reevaluation of a concept. J Clin Endocrinol Metab 1990 ; 70 : 1494-5.
27. Rosenfield RL, Heike J. Is an immunoassay available for the measurement of bioactive LH in serum ? J Androl 1992 ; 13 : 1-10.
28. Contreras H, Ronco AM. Leydig cell heterogeneity as judged by quantitative cytochemistry of 3β-hydroxysteroid dehydrogenase activity in individual rat Leydig cells. J Steroid Biochem Molec Biol 1994 ; 51 : 73-9.